Unione Europea - danese - EMA (European Medicines Agency)

ultragenyx germany gmbh - evinacumab - hyperkolesterolæmi - lipid modificerende midler - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - methylphenidathydrochlorid - depottabletter - 18 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - methylphenidathydrochlorid - depottabletter - 27 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - methylphenidathydrochlorid - depottabletter - 36 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - methylphenidathydrochlorid - depottabletter - 54 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - cabazitaxel - koncentrat og solvens til infusionsvæske, opløsning - 40 mg/ml

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - methylaminolevulinathydrochlorid - creme - 160 mg/g

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

nordic prime aps - roxithromycin - filmovertrukne tabletter - 150 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - lisinopril, vandfri - tabletter - 20 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - roxithromycin - filmovertrukne tabletter - 300 mg